^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Opal

    i
    Company:
    Cullinan Therap
    Drug class:
    PD1 inhibitor, CD137 agonist
    Related drugs: